Using amyloid PET to create FDG-like brain images
Part of Brain & nervous system, Mental health clinical trials.
This research study tests whether a computer can create a synthetic FDG PET image from an amyloid PET scan done for Alzheimer's evaluation. If you have had all three types of brain scans (amyloid PET, FDG PET, and MRI) in 2025, your data may help improve Alzheimer's diagnosis without extra tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 50 years or older.
- You had an amyloid PET scan (with Florbetaben or Flutemetamol) in 2025.
- You also had a standard FDG PET scan and an MRI scan within 6 months of that amyloid scan.
- All three scans need to be good quality (no major movement or technical issues).
- You do not have another major brain condition like Parkinson's disease or a recent stroke.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new type of brain scan ([18F]F-AraG PET) that may help detect Alzheimer's disease earlier or more accurately. Researchers will take pictures of your brain to see if this scan can identify changes related to Alzheimer's.
This study uses special brain scans (PET scans) to look for proteins linked to Alzheimer's disease. It aims to improve diagnosis and track how the disease progresses over time.
This study uses brain imaging to measure two things in the brain—amyloid protein and how the brain uses sugar. It may help researchers better understand early brain changes in people in the ALFA project.
This study compares two types of brain PET scans (tau and amyloid) to see which one better helps diagnose memory problems. You may be eligible if you have mild cognitive impairment or mild dementia and your doctor has already ordered an amyloid PET scan.
This study tests if a new radioactive tracer called [18F]-MFBG can help doctors better distinguish between Parkinson's disease, multiple system atrophy (MSA), dementia with Lewy bodies, and Alzheimer's disease. It compares the new scan with two standard scans to see which is most accurate.
This trial uses a new type of PET scan to look for specific proteins in the brain that are linked to Alzheimer's disease. It will help doctors see how these proteins relate to cognitive decline and compare scans from people with normal thinking to those with memory problems.
Hear when a new Alzheimer Disease (AD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.